胆脂瘤与儿童进行性感音神经性听力损失相关
本研究利用包含175215例患者的大型儿童听力学纵向数据集,通过线性回归分析诊断编码,发现胆脂瘤诊断编码与儿童进行性感音神经性听力损失相关,并提取58例胆脂瘤相关进行性听力损失与55例稳定性听力损失患者的纵向气骨导阈值,显示胆脂瘤患者存在与进行性感音神经性听力损失一致的掩蔽骨导敏感度变化;乳突切除术似乎未导致所观察到的进行性听力损失。
要点
- 胆脂瘤诊断编码与儿童进行性感音神经性听力损失相关。
- 胆脂瘤相关进行性听力损失患者可见与进行性感音神经性听力损失一致的掩蔽骨导变化。
- 许多胆脂瘤合并进行性听力损失患者首次测试时听阈正常。
核心结论
- 统计分析显示胆脂瘤与儿童进行性感音神经性听力损失存在关联。
- 作者认为胆脂瘤诊断儿童可能面临进行性感音神经性听力损失风险增加,即使已建立正常掩蔽骨导基线也应接受持续监测。
研究设计与样本
- 研究纳入听力学与遗传学数据库(Audiologic and Genetics Database)中175215例患者的记录,使用特定标准定义进行性听力损失。
- 采用线性回归模型比较进行性听力损失队列与稳定性听力损失组所有电子健康记录诊断编码的对数频率。
- 提取胆脂瘤相关进行性听力损失组(58例受试者)与稳定性听力损失组(55例受试者)的纵向气导(AC)和骨导(BC)阈值进行分析。
主要发现
- 线性回归分析识别出胆脂瘤诊断编码与儿童进行性感音神经性听力损失相关。
- 纵向听力学数据展示胆脂瘤诊断儿童存在与进行性感音神经性听力损失一致的受试者内掩蔽骨导敏感度变化。
- 额外分析显示乳突切除术似乎未导致所观察到的进行性听力损失。
- 许多胆脂瘤合并进行性听力损失患者在首次测试时听阈正常。
关键数值与推荐
- 原文未报告具体的诊断编码、回归系数、阈值数值或统计显著性指标。
临床怎么用
- 作者认为胆脂瘤诊断儿童可能面临进行性感音神经性听力损失风险增加,应接受持续监测,即使已建立正常掩蔽骨导基线。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study identified an association between cholesteatoma and progressive sensorineural hearing loss using a large pediatric longitudinal audiologic dataset. Cholesteatoma is a potential sequela of chronic otitis media with effusion, a commonly observed auditory pathology that can contribute to hearing loss in children. The purpose of this report is to (i) describe the process of identifying the association between cholesteatoma and progressive sensorineural hearing loss in a large pediatric dataset and (ii) describe the audiologic data acquired over time in patients identified with cholesteatoma-associated progressive sensorineural hearing loss. DESIGN: Records of patients included in the Audiologic and Genetics Database (n = 175,215 patients) were examined using specified criteria defining progressive hearing loss. A linear regression model examined the log frequency of all diagnostic codes in the electronic health record assigned to patients for a progressive hearing loss cohort compared with a stable hearing loss group. Based on findings from the linear regression analysis, longitudinal audiometric air (AC) and bone conduction (BC) thresholds were extracted for groups of subjects with cholesteatoma-associated progressive (n = 58 subjects) and stable (n = 55 subjects) hearing loss to further analyze changes in hearing over time. RESULTS: The linear regression analyses identified that diagnostic codes for cholesteatoma were associated with progressive sensorineural hearing loss in children. The longitudinal audiometric data demonstrated within-subject changes in masked BC sensitivity consistent with progressive sensorineural hearing loss in children diagnosed with cholesteatoma. Additional analyses showed that mastoidectomy surgeries did not appear to contribute to the observed progressive hearing loss and that a high number of cholesteatoma patients with progressive hearing loss had normal-hearing thresholds at their first test. CONCLUSIONS: The statistical analyses demonstrated an association between cholesteatoma and pediatric progressive sensorineural hearing loss. These findings inform clinical management by suggesting that children with cholesteatoma diagnoses may be at increased risk for progressive sensorineural hearing loss and should receive continued monitoring even after a normal masked BC baseline has been established.
引用
- Racca JM, Lee J, Sikorski F, et al. Cholesteatoma Is Associated With Pediatric Progressive Sensorineural Hearing Loss. Ear Hear. 2021. PMID: 34860720. doi:10.1097/AUD.0000000000001176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。